#DrugDelivery

Industry ExaminerIndustryExaminer
2026-01-13

Novartis just placed a $1.7B Alzheimer’s bet on a “boring” but decisive problem: BBB delivery. If only ~0.1% of IV antibodies reach the brain, “brain shuttles” could be the next moat. Full feature: biotech.industryexaminer.com/n

2026-01-03

Nhà khoa học trẻ TP.HCM phát triển vật liệu nano dẫn truyền thuốc trúng đích, hứa hẹn mở ra hướng mới trong điều trị ung thư. #nanotechnology #cancerresearch #TPHCM #khoahọc #y học #đột phá

#materials #science #research #oncology #innovation #Vietnam #HCMC #nanomaterials #drugdelivery #targetedtherapy

vtcnews.vn/nha-khoa-hoc-tre-tp

Omni Lettersomniletters
2026-01-01

Microneedles that could revolutionize cancer immunotherapy.

Made from natural polysaccharides, the new microneedles not only deliver drugs but also activate the immune system, paving the way for more effective and less invasive anticancer therapies.

Read more: omniletters.com/microneedles-t

Sinclair Tasinclairdta
2025-12-12

MIT just took a swing at one of the most annoying parts of modern medicine: hours‑long IV antibody infusions.

Their team figured out how to pack antibodies into tiny solid particles—about 100 microns wide—that stay suspended in liquid at ~360 mg/mL. That’s concentrated enough to deliver a full dose in about 2 mL, i.e., a normal subcutaneous injection, not a 100 mL drip.

mit-ki.org/4aHnV27

Newsrampnewsramp
2025-11-21

Dr. Muzykantov reveals breakthrough nanomedicine strategies in upcoming BOC Sciences webinar exploring vascular drug delivery targeting mechanisms and innovative therapeutic approaches

Newsramp Image
CSBJcsbj
2025-11-16

🧬 Can molecular simulations transform the future of long-acting diabetes treatments?

🔗 In silico investigations of albumin-GLP-1 receptor agonist complexes for diabetes drug delivery applications. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2025.11

📚 CSBJ: csbj.org/

In silico investigations of albumin-GLP-1 receptor agonist complexes for diabetes drug delivery applications. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.11.007
Markus Witzlersciuro@scicomm.xyz
2025-11-10

Happy to finally have my last results of my PhD project published in #CarbohydratePolymers: Ionic agarose derivatives as polyelectrolytic additives for controlled drug release.

Key highlights:
⚗️ Developed anionic and cationic agarose derivatives with tuneable degrees of substitution.
💧 Integrated these materials into hydrogels and alginate micro beads to enhance drug delivery performance.
⏱️ Achieved sustained and low-burst drug release over up to 14 days with advanced kinetic modelling for accurate release characterisation.

This research contributes to the development of biocompatible and efficient drug delivery systems with customisable release profiles. It now marks an end of this part of journey, where I have learned so much!

🔗 Read more: doi.org/10.1016/j.carbpol.2025

#ControlledRelease #DrugDelivery #Biomaterials #AgaroseDerivatives #Hydrogels #Chemistry #Polysaccharides #Science

Lexmilian S. R. B. de MelloPercarus@mastodon.au
2025-09-27
2025-09-23

The video 🎥 of the #BeilsteinTalk “Next-generation drug and vaccine delivery for global health” with Ana Jaklenec from the Massachusetts Institute of Technology, is NOW available 🔓 in the video portal @TIB_AVPortal of the @tibhannover.

🔗 av.tib.eu/media/71586
#DrugDelivery #vaccines #GlobalHealth #CancerImmunotherapy #BeilsteinTalks

2025-09-19

The video 🎥 of the #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, is NOW available 🔓 in the video portal @TIB_AVPortal of the @tibhannover.
🔗 av.tib.eu/media/71537
#DrugDelivery #siRNA
#BeilsteinTalks

Credence Research Europe LTDcredenceresearch
2025-09-19

The microfluidic components market is experiencing significant growth, expected to reach USD 12.17 billion by 2032.

🔹 Top Companies:

Danaher Corporation

Illumina Inc.

PerkinElmer Inc.

Agilent Technologies Inc.

Bio-Rad Laboratories Inc.

Thermo Fisher Scientific Inc.

For detailed insights, view the full report: credenceresearch.com/report/mi

2025-08-29

#ActaMateriaMedica: 'Innovations and challenges in bioresponsive materials for effective drug delivery in diabetes mellitus' - an article on #ScienceOpen 🔓📄🔗 scienceopen.com/hosted-documen

#BioresponsiveMaterials #GlucoseResponsive #DrugDelivery #DiabetesResearch #Nanomedicine

Newsrampnewsramp
2025-08-14

Creative Biolabs expands liposomal drug delivery services, offering breakthrough technologies for gene therapy and molecular medicine research. Customized solutions transforming pharmaceutical innovation.

2025-08-05

Starting TODAY 📅 Aug 5, 2025, at 🕞 3:30 pm CEST: Online #BeilsteinTalk “Next-generation drug and vaccine delivery for global health” with Ana Jaklenec from the Massachusetts Institute of Technology.

There’s still time to register for FREE 🔗 beilstein-institut.de/en/talks

#DrugDelivery #vaccines #GlobalHealth #CancerImmunotherapy #BeilsteinTalks

2025-07-31

Invitation to join the online #BeilsteinTalk “Next-generation drug and vaccine delivery for global health” with Ana Jaklenec from the Massachusetts Institute of Technology on 📅 Aug 5, 2025, 🕞 3:30–4:30 pm CEST.

Participation is FREE – just register 🔗 beilstein-institut.de/en/talks

#DrugDelivery #vaccines #GlobalHealth #CancerImmunotherapy #BeilsteinTalks

2025-07-25

Save the date: 📅 Aug 5, 2025 🕞 3:30–4:30 pm CEST
Online #BeilsteinTalk “Next-generation drug and vaccine delivery for global health” with Ana Jaklenec from the Massachusetts Institute of Technology.

Register for FREE! 🔗 beilstein-institut.de/en/talks

#DrugDelivery #vaccines #GlobalHealth #CancerImmunotherapy #BeilsteinTalks

Meenakshi BishtMeenakshi12
2025-07-24

The global pharma packaging market is evolving with demand for smart, sustainable, and tamper-proof solutions across biologics, generics, and vaccines.
🔗 kenresearch.com/industry-repor

Newsrampnewsramp
2025-06-24

Creative Biolabs advances liposome technology, offering breakthrough drug delivery solutions across multiple medical applications. Precision engineering meets pharmaceutical innovation.

Newsramp Image
Leibniz Supercomputing CentreLRZ_DE
2025-06-17

Forschende der Ludwig-Maximilians-Universität München (LMU) suchen nach Strategien, RNA-basierte Medikamente zielgerichtet im Körper zu platzieren. Welche Rolle Nanopartikel beim Transport spielen, zeigten Simulationen an den Supercomputern des LRZ: lrz.de/news/detail/wege-von-me

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst